Cargando…

Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study

OBJECTIVES: The primary objective of this pilot study was to investigate whether the therapeutic drug monitoring of imipenem could be performed with spent effluent instead of blood sampling collected from critically ill patients under continuous renal replacement therapy. METHODS: A prospective open...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Aiping, Li, Zhe, Yu, Junxian, Li, Ren, Cheng, Sheng, Duan, Meili, Bai, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836878/ https://www.ncbi.nlm.nih.gov/pubmed/27093294 http://dx.doi.org/10.1371/journal.pone.0153927

Ejemplares similares

Continuous vs bolus administration of imipenem in critically ill patients with ICU-acquired pneumonia
por: Sakka, S, et al.
Publicado: (2004)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
por: Zhai, Yiling, et al.
Publicado: (2023)

1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy
por: Henry, Molly, et al.
Publicado: (2021)

Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy
por: Zhou, Xiong, et al.
Publicado: (2023)

Population-Based Pharmacokinetics and Dose Optimization of Imipenem in Vietnamese Critically-Ill Patients
por: Dinh, Thanh D, et al.
Publicado: (2022)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy
por: Kim, Il Young, et al.
Publicado: (2017)

Assessment of severity scoring systems for predicting mortality in critically ill patients receiving continuous renal replacement therapy
por: Park, Hyunmyung, et al.
Publicado: (2023)

Advances in the Removal of Cr(III) from Spent Industrial Effluents—A Review
por: Staszak, Katarzyna, et al.
Publicado: (2022)

Reddish‐purple effluent fluid induced by hydroxocobalamin in continuous renal replacement therapy
por: Yamamoto, Miyuki, et al.
Publicado: (2022)

Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study
por: Jiang, Sai-Ping, et al.
Publicado: (2014)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
por: Chaijamorn, Weerachai, et al.
Publicado: (2018)

Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
por: Hall, Anna, et al.
Publicado: (2020)

Assessment of the Potential of Using Nanofiltration Polymeric and Ceramic Membranes to Treat Refinery Spent Caustic Effluents
por: Rita, Ana Isabel, et al.
Publicado: (2022)

Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy
por: Wu, Lingping, et al.
Publicado: (2017)

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015)

Decolorization of Distillery Spent Wash Using Biopolymer Synthesized by Pseudomonas aeruginosa Isolated from Tannery Effluent
por: David, Charles, et al.
Publicado: (2015)

Bioremediation of Textile Industrial Effluents Using Nutraceutical Industrial Spent: Laboratory-Scale Demonstration of Circular Economy
por: Taqui, Syed Noeman, et al.
Publicado: (2022)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
por: de Velde, Femke, et al.
Publicado: (2021)

Nomogram Prediction Model of Hypernatremia on Mortality in Critically Ill Patients
por: Qi, Zhili, et al.
Publicado: (2023)

1087. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients with Augmented Renal Clearance (ARC)
por: Fratoni, Andrew J, et al.
Publicado: (2021)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Utility of Volume Assessment Using Bioelectrical Impedance Analysis in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective Observational Study
por: Park, Ki Hyun, et al.
Publicado: (2017)

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series
por: Mornese Pinna, Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0ts2upiv49lorvfs2b967ege0